Dapagliflozin Effect in Cognitive Impairment in Stroke Trial

Clinical trial NCT05565976 · UNKNOWN

Trial details

NCT number: NCT05565976
Sponsor: Jaime Daniel Mondragon
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Stroke, Ischemic Mild Cognitive Impairment Dementia, Vascular Metabolic Syndrome

Start date: 2020-08-01
Primary completion: 2024-12-31
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.